22/10/2014 - 17:29
VIENNA – Patients treated with an anti–tumor necrosis factor drug had a 5% annual rate of developing one or more psoriasiform skin lesions in a review of more than 400 patients who received these...
Field of Interest: Dermatology
Categories:
News Feed: Internal Medicine News - Dermatology